Smoking and haptoglobin phenotype modulate serum ferritin and haptoglobin levels in Parkinson disease

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Journal of neural transmission

• Publication date

  2016-06-27

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00702-016-1590-xPMID 27349967PMCID PMC5096643
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Haptoglobin phenotype modifies serum iron levels and the effect of smoking on Parkinson disease risk.

  2015cited by this paper
• Haptoglobin: the hemoglobin detoxifier in plasma.

  2013influential reference
• Environmental tobacco smoke and Parkinson's disease

  2012cited by this paper
• Substantia nigra echogenicity in Parkinson’s disease: relation to serum iron and C-reactive protein

  2011cited by this paper
• Serum ferritin is derived primarily from macrophages through a nonclassical secretory pathway.

  2010cited by this paper
• Iron and reactive oxygen species activity in parkinsonian substantia nigra.

  2010cited by this paper
• Association Between Lifetime Cigarette Smoking and Lewy Body Accumulation

  2010cited by this paper
• Neuroprotective Role of Haptoglobin after Intracerebral Hemorrhage

  2009influential reference
• Particulate matter in cigarette smoke alters iron homeostasis to produce a biological effect.

  2008cited by this paper
• The functional polymorphism of the hemoglobin‐binding protein haptoglobin influences susceptibility to idiopathic Parkinson's disease

  2008cited by this paper
• Pooled analysis of tobacco use and risk of Parkinson disease.

  2007cited by this paper
• ELISA reveals a difference in the structure of substantia nigra ferritin in Parkinson's disease and incidental Lewy body compared to control.

  2007cited by this paper
• Monitoring micronutrients in cigarette smokers.

  2007cited by this paper
• Medical check-up findings characteristic of smokers: aimed at improving smoking cessation interventions by physicians.

  2006cited by this paper
• A clinic-based study of the LRRK2 gene in Parkinson disease yields new mutations

  2005cited by this paper
• Ironing Iron Out in Parkinson's Disease and Other Neurodegenerative Diseases with Iron Chelators: A Lesson from 6‐Hydroxydopamine and Iron Chelators, Desferal and VK‐28

  2004cited by this paper
• Echogenicity of the substantia nigra: association with increased iron content and marker for susceptibility to nigrostriatal injury.

  2002cited by this paper
• Structure-function analysis of the antioxidant properties of haptoglobin.

  2001influential reference
• Role of Free Radicals in the Neurodegenerative Diseases

  2001cited by this paper
• Identification of the haemoglobin scavenger receptor

  2001cited by this paper
• Molecular heterosis: a review.

  2000cited by this paper
• Biological and clinical significance of haptoglobin polymorphism in humans.

  1996influential reference
• Evidence against the operation of selective mortality in explaining the association between cigarette smoking and reduced occurrence of idiopathic Parkinson disease.

  1996cited by this paper
• Inhibition of monoamine oxidase B in the brains of smokers

  1996cited by this paper
• A Quantitative Analysis of Isoferritins in Select Regions of Aged, Parkinsonian, and Alzheimer's Diseased Brains

  1995cited by this paper
• Iron and ferritin in inflammation and cancer.

  1994cited by this paper
• Hemoglobin binding with haptoglobin: Delineation of the haptoglobin binding site on the α-chain of human hemoglobin

  1990cited by this paper
• Smoke inhalation: diagnosis and treatment.

  1989cited by this paper
• Smoke inhalation: diagnosis and treatment.

  1989cited by this paper
• A comparison of clinical and pathological features of young‐ and old‐onset Parkinson's disease

  1988cited by this paper
• Haptoglobin groups in motor neuron disease.

  1988cited by this paper
• Haptoglobin: the evolutionary product of duplication, unequal crossing over, and point mutation.

  1982cited by this paper
• Evaluation of the iron status of a population.

  1976influential reference
• Ferritin in serum. Clinical and biochemical implications.

  1975cited by this paper
• Ferritin in serum.

  1973cited by this paper
• The Effect of Haptoglobin Polymer Size on Hemoglobin Binding Capacity *

  1965influential reference

• Proposed mechanisms of neuroprotection for nicotine in Parkinson's disease

  2025cites this paper
• The Association between Serum Oxidative Stress Indexes and Pathogenesis of Parkinson’s Disease in the Northwest of Iran

  2021cites this paper
• Biological fluid levels of iron and iron‐related proteins in Parkinson’s disease: Review and meta‐analysis

  2020influential citation
• iTRAQ-based proteomics analysis of hippocampus and striatum in rats with hyperglycemia and Parkinson ’ s disease

  2018cites this paper
• Peroxiredoxin-2 and zinc-alpha-2-glycoprotein as potentially combined novel salivary biomarkers for early detection of oral squamous cell carcinoma using proteomic approaches.

  2018cites this paper
• Dysregulation of serum NADPH oxidase1 and ferritin levels provides insights into diagnosis of Parkinson's disease.

  2017cites this paper
• Lower hemoglobin levels in patients with parkinson's disease are associated with disease severity and iron metabolism.

  2017cites this paper
• NEUROLOGY AND PRECLINICAL

  year unknowncites this paper